9-136832282-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_024718.5(RABL6):āc.617A>Gā(p.Tyr206Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000049 in 1,613,672 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000026 ( 0 hom., cov: 32)
Exomes š: 0.000051 ( 0 hom. )
Consequence
RABL6
NM_024718.5 missense
NM_024718.5 missense
Scores
2
11
6
Clinical Significance
Conservation
PhyloP100: 6.97
Genes affected
RABL6 (HGNC:24703): (RAB, member RAS oncogene family like 6) This gene encodes a member of the Ras superfamily of small GTPases. The encoded protein binds to both GTP and GDP and may play a role in cell growth and survival. Overexpression of this gene may play a role in breast cancer tumorigenesis, and pseudogenes of this gene are located on the long arm of chromosome 2 and the short arm of chromosome 18. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RABL6 | NM_024718.5 | c.617A>G | p.Tyr206Cys | missense_variant | 7/15 | ENST00000311502.12 | NP_078994.3 | |
RABL6 | NM_001173988.2 | c.620A>G | p.Tyr207Cys | missense_variant | 7/15 | NP_001167459.1 | ||
RABL6 | NM_001173989.4 | c.617A>G | p.Tyr206Cys | missense_variant | 7/8 | NP_001167460.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RABL6 | ENST00000311502.12 | c.617A>G | p.Tyr206Cys | missense_variant | 7/15 | 1 | NM_024718.5 | ENSP00000311134.7 | ||
RABL6 | ENST00000357466.6 | c.617A>G | p.Tyr206Cys | missense_variant | 7/10 | 1 | ENSP00000350056.2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152038Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152038
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000803 AC: 20AN: 249164Hom.: 0 AF XY: 0.000104 AC XY: 14AN XY: 135200
GnomAD3 exomes
AF:
AC:
20
AN:
249164
Hom.:
AF XY:
AC XY:
14
AN XY:
135200
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000513 AC: 75AN: 1461516Hom.: 0 Cov.: 31 AF XY: 0.0000701 AC XY: 51AN XY: 727054
GnomAD4 exome
AF:
AC:
75
AN:
1461516
Hom.:
Cov.:
31
AF XY:
AC XY:
51
AN XY:
727054
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74396
GnomAD4 genome
AF:
AC:
4
AN:
152156
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74396
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
9
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2023 | The c.620A>G (p.Y207C) alteration is located in exon 7 (coding exon 7) of the RABL6 gene. This alteration results from a A to G substitution at nucleotide position 620, causing the tyrosine (Y) at amino acid position 207 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M;M;.;M;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D;D;.
REVEL
Uncertain
Sift
Benign
T;T;T;T;.
Sift4G
Benign
T;T;T;T;T
Polyphen
1.0
.;D;D;.;.
Vest4
MutPred
Loss of phosphorylation at Y206 (P = 0.0891);Loss of phosphorylation at Y206 (P = 0.0891);.;Loss of phosphorylation at Y206 (P = 0.0891);.;
MVP
MPC
0.035
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at